Advertisement

Topics

Samsung Bioepis eyes branded biologics

05:23 EDT 22 Aug 2017 | SmartBrief

Biosimilar-drug maker Samsung Bioepis is working with Takeda to develop new biologic drugs, including one for acute pancreati -More

Original Article: Samsung Bioepis eyes branded biologics

NEXT ARTICLE

More From BioPortfolio on "Samsung Bioepis eyes branded biologics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...